447 related articles for article (PubMed ID: 18550275)
1. Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives.
Kundu JK; Surh YJ
Cancer Lett; 2008 Oct; 269(2):243-61. PubMed ID: 18550275
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol and cellular mechanisms of cancer prevention.
Shukla Y; Singh R
Ann N Y Acad Sci; 2011 Jan; 1215():1-8. PubMed ID: 21261635
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of chemoprevention by resveratrol: NF-kappaB and AP-1 as potential targets.
Kundu JK; Surh YJ
Mutat Res; 2004 Nov; 555(1-2):65-80. PubMed ID: 15476852
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of the chemopreventive effects of resveratrol and its analogs in carcinogenesis.
Ulrich S; Wolter F; Stein JM
Mol Nutr Food Res; 2005 May; 49(5):452-61. PubMed ID: 15830333
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis induction by sulfur-containing compounds in malignant and nonmalignant human cells.
Fimognari C; Lenzi M; Hrelia P
Environ Mol Mutagen; 2009 Apr; 50(3):171-89. PubMed ID: 19170195
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol suppresses interleukin-1beta-induced inflammatory signaling and apoptosis in human articular chondrocytes: potential for use as a novel nutraceutical for the treatment of osteoarthritis.
Shakibaei M; Csaki C; Nebrich S; Mobasheri A
Biochem Pharmacol; 2008 Dec; 76(11):1426-39. PubMed ID: 18606398
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Potential and Molecular Targets of Piceatannol in Chronic Diseases.
Surh YJ; Na HK
Adv Exp Med Biol; 2016; 928():185-211. PubMed ID: 27671818
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol modulates phorbol ester-induced pro-inflammatory signal transduction pathways in mouse skin in vivo: NF-kappaB and AP-1 as prime targets.
Kundu JK; Shin YK; Surh YJ
Biochem Pharmacol; 2006 Nov; 72(11):1506-15. PubMed ID: 16999939
[TBL] [Abstract][Full Text] [Related]
9. Rhein inhibits angiogenesis and the viability of hormone-dependent and -independent cancer cells under normoxic or hypoxic conditions in vitro.
Fernand VE; Losso JN; Truax RE; Villar EE; Bwambok DK; Fakayode SO; Lowry M; Warner IM
Chem Biol Interact; 2011 Jul; 192(3):220-32. PubMed ID: 21457705
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol and breast cancer chemoprevention: molecular mechanisms.
Le Corre L; Chalabi N; Delort L; Bignon YJ; Bernard-Gallon DJ
Mol Nutr Food Res; 2005 May; 49(5):462-71. PubMed ID: 15786518
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of cyclin D1 is associated with decreased levels of p38 MAP kinases, Akt/PKB and Pak1 during chemopreventive effects of resveratrol in liver cancer cells.
Parekh P; Motiwale L; Naik N; Rao KV
Exp Toxicol Pathol; 2011 Jan; 63(1-2):167-73. PubMed ID: 20133117
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol addiction: to die or not to die.
Shakibaei M; Harikumar KB; Aggarwal BB
Mol Nutr Food Res; 2009 Jan; 53(1):115-28. PubMed ID: 19072742
[TBL] [Abstract][Full Text] [Related]
13. Review. Pro- and anti-angiogenesis effects of resveratrol.
Chen Y; Tseng SH
In Vivo; 2007; 21(2):365-70. PubMed ID: 17436589
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol: a natural polyphenol with multiple chemopreventive properties.
Brisdelli F; D'Andrea G; Bozzi A
Curr Drug Metab; 2009 Jul; 10(6):530-46. PubMed ID: 19702538
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol inhibits VEGF expression of human hepatocellular carcinoma cells through a NF-kappa B-mediated mechanism.
Yu HB; Zhang HF; Zhang X; Li DY; Xue HZ; Pan CE; Zhao SH
Hepatogastroenterology; 2010; 57(102-103):1241-6. PubMed ID: 21410066
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo.
Garvin S; Ollinger K; Dabrosin C
Cancer Lett; 2006 Jan; 231(1):113-22. PubMed ID: 16356836
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol: a review of preclinical studies for human cancer prevention.
Athar M; Back JH; Tang X; Kim KH; Kopelovich L; Bickers DR; Kim AL
Toxicol Appl Pharmacol; 2007 Nov; 224(3):274-83. PubMed ID: 17306316
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol inhibits hypoxia-induced metastasis potential enhancement by restricting hypoxia-induced factor-1 alpha expression in colon carcinoma cells.
Wu H; Liang X; Fang Y; Qin X; Zhang Y; Liu J
Biomed Pharmacother; 2008 Nov; 62(9):613-21. PubMed ID: 18674879
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol modulation of signal transduction in apoptosis and cell survival: a mini-review.
Fulda S; Debatin KM
Cancer Detect Prev; 2006; 30(3):217-23. PubMed ID: 16872757
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol and liver disease: from bench to bedside and community.
Bishayee A; Darvesh AS; Politis T; McGory R
Liver Int; 2010 Sep; 30(8):1103-14. PubMed ID: 20557453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
